CTOs on the Move

St Charles Parish Hospital

www.stch.net

 
St Charles Parish Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Luling, LA. To find more information about St Charles Parish Hospital, please visit www.stch.net
  • Number of Employees: 1K-5K
  • Annual Revenue: $10-50 Million
  • www.stch.net
  • 1057 Paul Maillard Rd
    Luling, LA USA 70070-4349
  • Phone: 985.785.3662

Executives

Name Title Contact Details

Similar Companies

Residential Medical Supply

Residential Medical Supply is a Oxford, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Community Health Center of Snohomish County

Community Health Center of Snohomish County (CHC) is a non-profit, Federally Qualified Community Health Center providing medical, dental, pharmacy, behavioral health, and additional ancillary services to nearly 70,000 individuals with 243,049 visits in 2021. For over 35 years, CHC has provided services to Snohomish County residents who face barriers to health care with the mission to provide our diverse community with access to high-quality, affordable primary health care. CHC operates seven medical primary care clinics, two medical walk-in clinics, six dental clinics, and five pharmacies, located in convenient locations in Arlington, Edmonds, Everett, and Lynnwood.

Alva Amco Pharmacal Companies, Inc.

Alva Amco Pharmacal Companies, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Niles, IL. To find more information about Alva Amco Pharmacal Companies, Inc., please visit www.alva-amco.com

Dailey Resources

Dailey Resources Ltd is a Scranton, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals is a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company`s pipeline leverages its proprietary Durasert® technology for sustained intraocular drug delivery including EYP-1901, a potential six-month intravitreal anti-VEGF treatment initially targeting wet age-related macular degeneration. Durasert`s proven intravitreal drug delivery platform has been safely administered to thousands of patients` eyes across four U.S. FDA-approved products, including YUTIQ® for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye, which is currently marketed by the Company. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts.